August 6, 2014 — A woman from Louisiana has filed a lawsuit against Daiichi Sankyo, the manufacturer of Benicar (olmesartan), alleging that the drug caused her to suffer more than three years of sprue-like enteropathy, a disease that causes chronic diarrhea and severe weight loss.
The lawsuit was filed on August 1 in the U.S. District Court for the Eastern District of Louisiana. The plaintiff, Bernadette Bujol-Brown, was prescribed Benicar HCT in May 2006 and used it until August 2013.
Four years after starting Benicar, in the spring of 2010, she began experiencing gastrointestinal symptoms including abdominal pain, nausea, vomiting, and diarrhea. When she visited her doctor, she was referred to the hospital for testing.
After an endoscopy on April 9, 2010, doctors found that she had active bleeding and numerous lesions in her intestines. She had another endoscopy on April 23, 2010 to treat symptoms in her upper gastrointestinal tract. Unfortunately, problems persisted. In November 2013, she had an endoscopy to remove hematin throughout her stomach.
In August 2013, Bujol-Brown’s doctor sent her a letter with information about the risk of enteropathy. When she discontinued Benicar, her symptoms improved. She is now seeking compensation and punitive damages for her pain and suffering, past and future medical expenses, economic losses, permanent injuries, and more.
Lawsuits Filed After FDA Warning
The U.S. Food and Drug Administration (FDA) warned about the link between Benicar and sprue-like enteropathy in July 2013. The label on Benicar was updated to include risk information about severe symptoms, including diarrhea and weight-loss, which might not appear for months or years after a patient starts Benicar. In some cases, patients had to be hospitalized. Enteropathy has not been linked to other blood pressure drugs in the same class as Benicar.
Daiichi Sankyo has been hit with several lawsuits from people who were injured by enteropathy. The Japanese drug-maker is accused of failing to warn about the risk of enteropathy, failing to adequately test Benicar before marketing it as safe and effective, and selling a defective and unreasonably dangerous pharmaceutical drug.
Do I have a Benicar Lawsuit?
The Schmidt Firm, PLLC is currently accepting Benicar induced injury cases in all 50 states. If you or somebody you know has been injured by sprue-like enteropathy, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.